Tillman Hartley LLC’s AbbVie ABBV Stock Holding History

Tillman Hartley LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$647K	Sell	2,974 -522	-15%	-$116K	0.16%	57
2025 Q4	$799K	Buy	3,496 +121	+4%	+$27.6K	0.2%	52
2025 Q3	$781K	Buy	3,375 +129	+4%	+$26.3K	0.2%	52
2025 Q2	$603K	Buy	3,246 +160	+5%	+$29.7K	0.17%	57
2025 Q1	$647K	Sell	3,086 -880	-22%	-$171K	0.19%	48
2024 Q4	$705K	Sell	3,966 -160	-4%	-$29.4K	0.2%	48
2024 Q3	$815K	Hold	4,126	–	–	0.24%	40
2024 Q2	$708K	Sell	4,126 -418	-9%	-$69.2K	0.24%	42
2024 Q1	$827K	Sell	4,544 -93	-2%	-$16K	0.28%	36
2023 Q4	$719K	Hold	4,637	–	–	0.27%	38
2023 Q3	$691K	Sell	4,637 -771	-14%	-$113K	0.28%	38
2023 Q2	$729K	Hold	5,408	–	–	0.29%	36
2023 Q1	$862K	Hold	5,408	–	–	0.37%	31
2022 Q4	$874K	Buy	+5,408	New	+$829K	0.38%	30

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tillman Hartley LLC's ABBV Position: Q1 2026 in Review

Tillman Hartley LLC reduced its AbbVie (ABBV) stake by 15% in Q1 2026, selling an estimated $116K and leaving 2,974 shares worth $647K. The position accounts for 0.16% of the portfolio, ranked #57.

Tillman Hartley LLC first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $874K in Q4 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Tillman Hartley LLC held 2,974 shares of AbbVie worth $647K as of Q1 2026.
Tillman Hartley LLC sold 522 AbbVie shares in Q1 2026, an estimated $116K.
AbbVie made up 0.16% of Tillman Hartley LLC's portfolio in Q1 2026, its #57 holding.
Tillman Hartley LLC first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Tillman Hartley LLC's AbbVie position peaked at $874K in Q4 2022.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Tillman Hartley LLC's 13F filing for Q1 2026, filed 8 May 2026.